Switch to:

Regeneron Pharmaceuticals Gross Profit

: $7,055 Mil (TTM As of Jun. 2020)
View and export this data going back to 1991. Start your Free Trial

Regeneron Pharmaceuticals's gross profit for the three months ended in Jun. 2020 was $1,677 Mil. Regeneron Pharmaceuticals's gross profit for the trailing twelve months (TTM) ended in Jun. 2020 was $7,055 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Regeneron Pharmaceuticals's gross profit for the three months ended in Jun. 2020 was $1,677 Mil. Regeneron Pharmaceuticals's Revenue for the three months ended in Jun. 2020 was $1,952 Mil. Therefore, Regeneron Pharmaceuticals's Gross Margin % for the quarter that ended in Jun. 2020 was 85.89%.

Regeneron Pharmaceuticals had a gross margin of 85.89% for the quarter that ended in Jun. 2020 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Regeneron Pharmaceuticals was 99.54%. The lowest was 88.21%. And the median was 93.39%.


Regeneron Pharmaceuticals Gross Profit Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Regeneron Pharmaceuticals Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Gross Profit Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3,711.02 4,560.70 5,475.10 6,276.70 7,081.20

Regeneron Pharmaceuticals Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
Gross Profit Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,432.00 1,821.80 1,945.60 1,610.90 1,676.50

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Regeneron Pharmaceuticals Gross Profit Distribution

* The bar in red indicates where Regeneron Pharmaceuticals's Gross Profit falls into.



Regeneron Pharmaceuticals Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Regeneron Pharmaceuticals's Gross Profit for the fiscal year that ended in Dec. 2019 is calculated as

Gross Profit (A: Dec. 2019 )=Revenue - Cost of Goods Sold
=7863.4 - 782.2
=7,081

Regeneron Pharmaceuticals's Gross Profit for the quarter that ended in Jun. 2020 is calculated as

Gross Profit (Q: Jun. 2020 )=Revenue - Cost of Goods Sold
=1952 - 275.5
=1,677

Gross Profit for the trailing twelve months (TTM) ended in Jun. 2020 was 1821.8 (Sep. 2019 ) + 1945.6 (Dec. 2019 ) + 1610.9 (Mar. 2020 ) + 1676.5 (Jun. 2020 ) = $7,055 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Regeneron Pharmaceuticals's Gross Margin % for the quarter that ended in Jun. 2020 is calculated as

Gross Margin % (Q: Jun. 2020 )=Gross Profit (Q: Jun. 2020 ) / Revenue (Q: Jun. 2020 )
=(Revenue - Cost of Goods Sold) / Revenue
=1,677 / 1952
=85.89 %

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Regeneron Pharmaceuticals  (NAS:REGN) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Regeneron Pharmaceuticals had a gross margin of 85.89% for the quarter that ended in Jun. 2020 => Durable competitive advantage


Regeneron Pharmaceuticals Gross Profit Related Terms


Regeneron Pharmaceuticals Gross Profit Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)